Global pharmaceutical companies have urged the Irish government to oppose new EU laws that will slash the amount of time between the launch of a new drug and rival firms being able to develop competing products.
The global chief executives of 27 companies wrote to Taoiseach Leo Varadkar in March raising concern over the proposals, which are the first major overhaul of the EU’s medicines regulations in 20 years and aim to make access to ...
Hemos resumido esta noticia para que puedas leerla rápidamente. Si estás interesado en la noticia, puedes leer el texto completo aquí. Leer más: